Komatsu, R., et al., Diabetes, 38:902-905 (1989). |
Orskov, C., et al., J. Biol. Chem., 264(22):12826-12829 (1989). |
Majsov, S., Int. J. Peptide Protein Res., 40-333-343 (1989). |
Holz, G.G., et al., Nature, 361:362-365 (1993). |
Orskov, C., Diabetologia, 35:701-711 (1992). |
Mentlein, R., et al., Eur. J. Biochem., 214:829-835 (1993). |
Handbook of Experimental Pharmacology, Springer-Verlag, Hasselblatt, et al., (Eds.), 32(2):729-777 (1975). |
Nauck, M.A., et al., J. Clin. Invest., 91:301-307 (1993). |
Nauck, M.A., et al., Diabetologia, 36:741-744 (1993). |
Gutniak, M., et al., N. E. J. Med., 326(20):1316-1322, (1992). |
Thorens, B., et al., Diabetes, 42:1219-1225 (1993). |
Levine-Pinto, H., et al., Biochem. Biophys. Res. Commun., 103(4) :1121-1130 (1981). |
Owa, T., et al., Chem. Letters: 873-874 (1988). |
Altman, J., et al., Synthetic Commun., 19(11 & 12) :2069-2076 (1989). |
O'Donnell, M.J., et al., Synthetic Commun., 19 (7 & 8) :1157-1165 (1989). |
Galloway, J.A., Diabetes Care, 13:1209-1239, (1990). |
Galloway, J.A., et al., Clin. Therap., 12:460-472 (1990). |
Suzuki, S., et al., Endocrinology, 125, 3109-3114, (1990). |
Ananthanancayanan, V.V., et al., Mol. Biol. Cell (Supp) 3, 250A (1992). |
Epand, R.M., Mol. Pharmacol. 22, 105-108 (1982). |
Pridal, L. et al., "Absorption of glucagon-like peptide-1 can be protracted by zinc or protamine", International Journal of Pharmaceutics 136 (1996) 53-59. |